Atlantic Health Partners

The MDAFP has a strong resource – Atlantic Health Partners – to help our members successfully address the financial and administrative challenges of providing immunizations to your patients.

Travel Vaccines: Planning Responsibly for Safe, Healthy Travel

Get international certificate of the vaccination before travel

July 20, 2021 – As more people become vaccinated against COVID-19, countries around the world are re-opening for travel and tourism. After more than a year of travel restrictions, experts expect that pent-up wanderlust since the start of the pandemic will result in an upsurge of summer travel in 2021.  

According to The Centers for Disease Control and Prevention’s (CDC) latest guidance regarding domestic and international travel, patients traveling should be fully vaccinated against COVID-19 to mitigate the risk of contracting and spreading the virus. But it’s not just COVID-19 that patients need protection from. Depending on the planned destination, patients may also need additional travel vaccines. By providing pre-travel consultation and care, providers have a significant role to play in preparing patients for safe, healthy travel in the coming months.  READ MORE

Infant Immunizations: The First Step to Lifelong Immunity

Doctor in rubber gloves wiping injection site on arm of little girl before vaccinate her for coronavirus

June 16, 2021 – As the worst of the COVID-19 pandemic appears to be behind us, we are just beginning to face the economic and humanitarian impact. The consequences of public health crises can be substantial — hence, the significance of immunizations in preventing vaccine preventable disease outbreaks. 

According to the Centers for Disease Control and Prevention (CDC), childhood immunizations between 1994 and 2018 has resulted in a net savings of $406 billion in direct costs and $1.9 trillion in total economic impact. With the highly anticipated return to in-person learning and play, infant immunizations are critical to preventing future outbreaks of vaccine preventable diseases for one of society’s most vulnerable age groups. As we inch towards a new normal and social activities resume, providers should emphasize the importance of infant immunizations to families who may have postponed their babies’ immunization appointments during the pandemic. READ MORE

Playing Catch-Up with Adolescent Immunization Before the Return to In-Person School


May 25, 2021 – As we learn more about the COVID-19 vaccines, federal guidance on who should receive them, and when, is changing quickly. As of late May 2021, The Centers for Disease Control and Prevention (CDC) has extended COVID-19 vaccine eligibility to include adolescents as young as 12 years old. The agency’s newest clinical guidance also approves co-administration stating, “COVID-19 vaccines and other vaccines may now be administered without regard to timing.” The updated guidance forgoes the previous two-week wait period before and after COVID-19 vaccine administration that posed challenges for providers trying to keep their patients on schedule with recommended immunizations, especially adolescents with various multi-dose immunizations.  READ MORE

Protecting the Most Vulnerable: Prevnar 13® & Pneumovax 23 Current Recommendations

February 23, 2021 – According to published research, there are two periods in our lives when our immune systems are particularly weak: as growing babies and aging seniors. For that reason, there are a few immunizations that the Centers for Disease Control and Prevention (CDC) recommends for both the youngest and oldest members of our society — among them, pneumococcal vaccination.

With children, uptake for pneumococcal vaccination is high, with the CDC reporting that 92% of children have received at least three doses. But among seniors 65 years of age or older, reports from CDC researchers show that vaccination rates are below the previous Healthy People 2020 target of 90% uptake. READ MORE

Preparing for the 2021-2022 Flu Season: Lessons Learned from COVID-19

January 19, 2021 – Although flu season generally runs from October through April, as noted by the Centers for Disease Control and Prevention (CDC), preparation is a year-round activity. The typical preparation providers and medical practices perform is routine and doesn’t vary much from year to year – except in 2020.

The COVID-19 pandemic added an unexpected complexity that upended typical flu season preparations but also provided lessons for dealing with unusual public health circumstances. While we cannot predict what 2021 will bring, by examining the current flu season, providers and practices can adopt a few principles to better prepare for and adapt to future flu seasons.

Prepare for the unexpected
Typically, providers begin preparing for the start of flu season at the top of the year between January and March, when pre-booking begins. Providers pre-book and reserve their vaccine supply based on population needs, taking into account age mix, allergies, and even anticipated growth in patient roster.

But in 2020, these factors were nearly impossible for providers to predict with patients under stay-at-home orders decreasing visits to outpatient and primary care centers. While in-person visits were dwindling, CDC Director Robert Redfield was already warning of a fall “twindemic” with the flu and COVID-19, leaving providers ready for pre-booking wading between overpreparing and under-preparing for the 2020-2021 flu season.

Atlantic Health Partners added Prevnar 13 to their comprehensive vaccine program!

December 4, 2020 – Exciting News from our immunization colleague Atlantic Health Partners – they have added Prevnar 13 to their comprehensive vaccine program! 

Atlantic Health Partners, the nation’s leading vaccine buying group, helps our members cost effectively strengthen their immunization efforts with these unique program features:

  • Best overall pricing and terms for all Merck, Sanofi Pasteur GlaxoSmithKline, Dynavax, and Pfizer vaccines including Prevnar 13!
  • Comprehensive flu program including Sanofi, Seqirus, GSK and AstraZeneca products.
    • Enrolling in Atlantic ensures you get complete information about all flu products to best prepare for the upcoming flu season
  • Excellent and timely customer service for all vaccine related issues including ordering, reimbursement support and advocacy.
  • Enrollment is easy and there is no cost to join.

We encourage you to contact Jeff Winokur or Cindy Berenson at or 800 741 2044 to determine how Atlantic can best meet your vaccine needs.

The HPV Vaccine: Expanding Its Role in Cancer Prevention

mri ct scan for cervical spine injury of patient.

November 10, 2020 – When the human papilloma virus (HPV) vaccine was first introduced in 2006, the primary purpose was to prevent cervical cancer caused by HPV in pre-teen girls and young women. Since then, the vaccine has proven to serve a broader community and recognized to prevent six types of cancer by the Center for Disease Control and Prevention (CDC).

Most recently, in June 2020, the U.S. Food & Drug Administration (FDA) approved the HPV vaccine, Gardasil 9, to prevent oropharyngeal and other head and neck cancers caused by HPV. Particularly as in-person care visits resume, providers have an opportunity to help patients catch up on preventative care measures they may have missed during the pandemic, including the HPV vaccine. READ MORE

Strengthening Your Vaccine Program to Weather Any Change

October 27, 2020 – While the COVID-19 pandemic has caused wide-ranging disruption across the healthcare industry, primary care practices have faced many additional challenges that impact all aspects of patient care, from diagnosing new conditions to vaccine administration. These changes require handoffs and continuity of care to ensure that patients’ care plans, especially preventative care like immunizations, are maintained.    

Even with disruptions, maintaining preventative health is a key way practices can protect their patient populations, particularly as we enter flu season amidst the ongoing pandemic.  READ MORE

Prevention is the Best Medicine: Making the Flu Vaccine a Part of COVID-19 Precautions this Fall

September 8, 2020 – From observing stay-at-home orders to wearing masks, people have taken numerous steps to protect not only themselves, but also their communities from the spread of COVID-19. Now, the upcoming flu season, which spans from October to May, presents another opportunity for Americans to step up and help keep each other healthy.

While it’s uncertain what effect flu season will have in tandem with the coronavirus pandemic, healthcare professionals can encourage their patients to receive the flu vaccine, as a preventative measure, as we head into the fall.  READ MORE

The Importance of Child and Teen Immunization Amid COVID-19

August 18, 2020 – The return to school each year often serves as a reminder for parents to review their children’s immunization records. While the impact of the COVID-19 pandemic means the start of this school year will look different for many, it does not lessen the importance of children getting vaccinated. In fact, as the virus continues to spread, protecting children against vaccine-preventable diseases is more important than ever. READ MORE

50 is the New 60: Making the Shingles Vaccine a Priority for Patients

July 28, 2020 – Each year, it’s estimated that millions of Americans are affected by shingles, and one in three Americans will have shingles in their lifetime according to the Centers for Disease Control and Prevention (CDC). In 2006 the first shingles vaccine, Zostavax, was approved for use and was more recently replaced by Shingrix as the CDC-recommended vaccine for adults 50 years of age and older.

Despite the prevalence of shingles and development of Shingrix, the CDC reports that only 33.4% of adults 60 years and older have received the shingles vaccine. A CDC study also found that coverage among adults aged 50 to 59 is only around 6%. These low rates of vaccination uptake and age disparities may be attributed to low rates of adult vaccination overall, a misunderstanding of who should receive the vaccine, or lack of awareness of available preventions. The current health risks associated with COVID-19 further emphasize the need for patients to utilize all preventative measures available, including vaccines, to maintain their overall wellbeing.

By educating patients on the effects of shingles and who needs the vaccine, providers can improve shingles vaccine uptake and ensure that their patients are protected against this painful disease.  READ MORE

Promoting Health Through Vaccine Uptake During the COVID-19 Crisis

June 16, 2020 – The COVID-19 pandemic has impacted all facets of the healthcare system, including providers and their patients. Some providers chose to close offices completely, while others rescheduled well visits to future dates. As a result, the Medical Group Management Association (MGMA) reports that practices cite a 60% decrease in patient volume since the start of the COVID-19 crisis.

Now, as providers begin to welcome patients back into their practices, and as patients begin to feel more comfortable returning to the doctor’s office for well visits, there is an opportunity for providers to ensure patients have received the vaccines they need. Given the current health risks associated with the coronavirus, it’s critical that patients have the best defense against vaccine-preventable diseases to maintain their overall health. Below, we highlight several considerations for providers as their patient visits begin to increase.  READ MORE

Developing New Vaccines: From Clinical Trials to Your Practice

May 26, 2020 – Facing the COVID-19 pandemic, scientists and manufacturers are working to develop a new vaccine that will protect against the virus. Though there is urgency surrounding the need for a coronavirus vaccine, there are many steps that go into the research, development, approval and manufacturing of a new vaccine. 

By understanding the vaccine development process, providers can ensure that their patients are well-educated about vaccine development and properly prepare their practices for any new vaccines that become available. READ MORE


Atlantic Health Partners has always been a strong resource for our members’ immunization efforts by offering the most favorable vaccine prices, terms, and purchasing support. We are pleased to share with you that Atlantic has expanded its program with the addition of GlaxoSmithKline (GSK) vaccines.  This include options for practices interested in the GSK portfolio or for those practices just interested in using Bexsero (Meningitis B vaccine). 

Atlantic now offers our members the full array of vaccine options to best meet your individual practice needs including:

  • Most favorable pricing for Sanofi, Merck, GSK, and Dynavax vaccines
  • A comprehensive flu program that includes Sanofi, GSK, and Seqirus products
  • Meningoccocal B vaccine options that include both Trumenba or Bexsero
  • No minimum quantity requirements to always receive most favorable pricing and terms
  • Excellent and timely customer service including reimbursement support and advocacy     

For information about the program please contact Jeff or Cindy at 800-741-2044 or

Disclaimer: The Maryland Academy of Family Physicians (MDAFP) has entered into a business relationship with Atlantic Health Partners to offer our members discounts and exclusive savings. This or other affinity program relationships presented by the MDAFP in no way implies a MDAFP endorsement of the program, supplier, or vendor.

© Copyright 2021 MDAFP or MDAFP Foundation • 210 Green Bay Rd • Thiensville, WI 53092 • Phone: 888-894-2606 • E-Mail: